Robotic Endoscopy Devices Market Size | CAGR Of 8.9%

The Global Robotic Endoscopy Devices Market is projected to reach approximately US$ 6.6 billion by 2034, rising from US$ 2.8 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 8.9% during the forecast period from 2025 to 2034. The market’s expansion can be attributed to rising demand for minimally invasive procedures, greater precision in diagnostics, and advancements in robotic-assisted technologies. As healthcare systems prioritize patient safety and quicker recovery, robotic endoscopy continues to gain traction across various surgical applications.

In terms of product type, the market is divided into diagnostic and therapeutic robotic endoscopy devices. Among these, therapeutic devices accounted for the largest market share, representing 56.7% in 2023. The dominance of the therapeutic segment is driven by its critical role in procedures requiring precision and intervention, such as tissue removal and targeted treatment. Enhanced control, reduced surgical errors, and real-time imaging support the growing adoption of therapeutic robotic systems in both inpatient and outpatient settings.

Based on application, the robotic endoscopy devices market is categorized into laparoscopy, colonoscopy, bronchoscopy, and others. Laparoscopy emerged as the leading application area, holding 38.5% of the market share in 2023. The preference for robotic-assisted laparoscopic surgeries is due to improved visualization, reduced trauma, and shorter hospital stays. These advantages make robotic laparoscopy a preferred choice in general surgery, gynecology, and urology, significantly contributing to market growth.

By end user, the market is segmented into hospitals and outpatient facilities. Hospitals dominated the market, holding the highest revenue share of 64.2% in 2023. This is due to the availability of advanced surgical infrastructure, skilled professionals, and higher procedure volumes. Hospitals continue to lead the adoption of robotic endoscopy systems due to their capability to manage complex procedures and integrate advanced surgical technologies within multidisciplinary departments.

Regionally, North America led the global robotic endoscopy devices market, capturing 41.5% of the total market share in 2023. This leadership position is supported by early technology adoption, strong healthcare funding, and the presence of major robotic system manufacturers. Favorable reimbursement policies and rising patient awareness have further strengthened market penetration in the U.S. and Canada. Ongoing research and clinical trials in robotic-assisted procedures are expected to maintain North America’s dominance throughout the forecast period.